WO2001042291A3 - Polynucleotides and polypeptides encoded thereby - Google Patents

Polynucleotides and polypeptides encoded thereby Download PDF

Info

Publication number
WO2001042291A3
WO2001042291A3 PCT/US2000/033538 US0033538W WO0142291A3 WO 2001042291 A3 WO2001042291 A3 WO 2001042291A3 US 0033538 W US0033538 W US 0033538W WO 0142291 A3 WO0142291 A3 WO 0142291A3
Authority
WO
WIPO (PCT)
Prior art keywords
tlmp
polypeptides
polynucleotides
polypeptides encoded
polynucleotide
Prior art date
Application number
PCT/US2000/033538
Other languages
French (fr)
Other versions
WO2001042291A2 (en
Inventor
John A Peyman
John Carulli
Jeff Browning
Catherine Hession
Original Assignee
Curagen Corp
Biogen Inc
John A Peyman
John Carulli
Jeff Browning
Catherine Hession
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curagen Corp, Biogen Inc, John A Peyman, John Carulli, Jeff Browning, Catherine Hession filed Critical Curagen Corp
Priority to AU20846/01A priority Critical patent/AU2084601A/en
Publication of WO2001042291A2 publication Critical patent/WO2001042291A2/en
Publication of WO2001042291A3 publication Critical patent/WO2001042291A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention provides polypeptides, designated herein as TLMP polypeptides, as well as polynucleotides encoding TLMP polypeptides, and antibodies that immunospecifically-bind to TLMP polypeptide or polynucleotide, or derivatives, variants, mutants or fragments thereof. The invention additionally provides methods in which the TLMP polypeptide, polynucleotide, and antibody are used in the detection, prevention, and treatment of a broad range of pathological states.
PCT/US2000/033538 1999-12-10 2000-12-11 Polynucleotides and polypeptides encoded thereby WO2001042291A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU20846/01A AU2084601A (en) 1999-12-10 2000-12-11 Novel polypeptides and polynucleotides encoding same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17025199P 1999-12-10 1999-12-10
US60/170,251 1999-12-10

Publications (2)

Publication Number Publication Date
WO2001042291A2 WO2001042291A2 (en) 2001-06-14
WO2001042291A3 true WO2001042291A3 (en) 2002-06-13

Family

ID=22619164

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/033538 WO2001042291A2 (en) 1999-12-10 2000-12-11 Polynucleotides and polypeptides encoded thereby

Country Status (2)

Country Link
AU (1) AU2084601A (en)
WO (1) WO2001042291A2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999058642A2 (en) * 1998-05-14 1999-11-18 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
WO1999064596A2 (en) * 1998-06-12 1999-12-16 Incyte Pharmaceuticals, Inc. Proteins regulating gene expression
WO2000058473A2 (en) * 1999-03-31 2000-10-05 Curagen Corporation Nucleic acids including open reading frames encoding polypeptides; 'orfx'

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999058642A2 (en) * 1998-05-14 1999-11-18 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
WO1999064596A2 (en) * 1998-06-12 1999-12-16 Incyte Pharmaceuticals, Inc. Proteins regulating gene expression
WO2000058473A2 (en) * 1999-03-31 2000-10-05 Curagen Corporation Nucleic acids including open reading frames encoding polypeptides; 'orfx'

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NAGASE T ET AL: "Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.", DNA RESEARCH, vol. 7, no. 4, 31 August 2000 (2000-08-31), pages 273 - 281, XP001012454 *

Also Published As

Publication number Publication date
AU2084601A (en) 2001-06-18
WO2001042291A2 (en) 2001-06-14

Similar Documents

Publication Publication Date Title
WO2001092523A3 (en) Human polynucleotides and polypeptides encoded thereby
WO2000058473A3 (en) Nucleic acids including open reading frames encoding polypeptides; 'orfx'
WO2001010902A8 (en) Nucleoc acids and secreted polypeptides encoded thereby
WO2001090366A3 (en) Human polynucleotides and polypeptides encoded thereby
WO2001036645A3 (en) Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same
WO2002066647A3 (en) Type 2 ctokine receptor and nucleic acids encoding same
WO2000053742A3 (en) Polynucleotides and proteins encoded thereby
WO2001049729A3 (en) Novex polypeptides, nucleic acids encoding same and their diagnostic and therapeutic use
WO2000078802A3 (en) Secreted polypeptides and corresponding polynucleotides
WO2001074856A3 (en) Wnt-7b-like polypeptides and nucleic acids encoding same
WO2002002625A3 (en) Novel fibroblast growth factors and nucleic acids encoding same
WO2001085767A3 (en) Human proteins polynucleotides encoding them and methods of using the same
WO2001062928A3 (en) Polypeptides and nucleic acids encoding same
WO2001070978A3 (en) Polypeptides and nucleic acids encoding same
WO2001005971A3 (en) Secreted polypeptides and corresponding polynucleotides
WO2001061009A3 (en) Polypeptides and nucleic acids encoding same
WO2001044473A3 (en) Polypeptides and nucleic acids encoding same
WO2001042471A8 (en) Polypeptides and polynucleotides encoding same
WO2001036638A3 (en) Polypeptides and nucleic acids encoding same
WO2000061754A3 (en) Human proteins and polynucleotides encoding them
WO2001079294A3 (en) Human proteins, polynucleotides encoding them and methods of using the same
WO2000070046A3 (en) Secreted polypeptides and corresponding polynucleotides
WO2001023572A3 (en) Polynucleotides and polypeptides encoded thereby
WO2001042291A3 (en) Polynucleotides and polypeptides encoded thereby
WO2001023561A3 (en) Novel polynucleotides encoding proteins containing thrombospondin type 1 repeats

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP